Clinical equivalence of evolocumab among patient subgroups in PROFICIO: a pooled analysis of 3146 patients from phase 3 studies

被引:0
|
作者
Stroes, E. [1 ]
Robinson, J. [2 ,3 ]
Raal, F. [4 ]
Dufour, R. [5 ]
Sullivan, D. [6 ]
Blagden, M. [7 ]
Kassahun, H. [8 ]
Yang, J. [9 ]
Wasserman, S. [9 ]
Koren, M. [10 ]
机构
[1] Acad Med Ctr Amsterdam, Dept Vasc Med, Amsterdam, Netherlands
[2] Univ Iowa, Dept Epidemiol, Iowa City, IA USA
[3] Univ Iowa, Dept Med, Iowa City, IA 52242 USA
[4] Univ Witwatersrand, Dept Med, ZA-2001 Johannesburg, South Africa
[5] Inst Rech Clin Montreal, Hypertens Clin, Montreal, PQ H2W 1R7, Canada
[6] Royal Prince Alfred Hosp, Dept Clin Biochem, Camperdown, NSW 2050, Australia
[7] Avondale Surg, Chesterfield, England
[8] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA
[9] Amgen Inc, Thousand Oaks, CA 91320 USA
[10] Jacksonville Ctr Clin Res, Jacksonville, FL USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P1756
引用
收藏
页码:307 / 308
页数:2
相关论文
共 50 条
  • [21] POOLED SAFETY ANALYSES FROM PHASE 3 STUDIES OF FILGOTINIB IN PATIENTS WITH RA
    Walker, David
    Winthrop, Kevin
    Genovese, Mark C.
    Combe, Bernard G.
    Tanaka, Yoshiya
    Kivitiz, Alan
    Matzkies, Franziska
    Bartok, Beatrix
    Ye, Lie
    Guo, Ying
    Tasset, Chantal
    Sundy, John S.
    Keystone, Edward
    Westhovens, Rene
    Rigby, William
    Burmester, Gerd R.
    RHEUMATOLOGY, 2020, 59
  • [22] Pooled Safety Analysis of Evolocumab in Over 6000 Patients From Double-Blind and Open-Label Extension Studies
    Toth, Peter P.
    Descamps, Olivier
    Genest, Jacques
    Sattar, Naveed
    Preiss, David
    Dent, Ricardo
    Djedjos, Constantine
    Wu, Yuna
    Geller, Michelle
    Uhart, Magdalena
    Somaratne, Ransi
    Wasserman, Scott M.
    CIRCULATION, 2017, 135 (19) : 1819 - +
  • [23] Renal safety of linagliptin in elderly patients with type 2 diabetes: analysis of pooled patient data from 7 phase 3 clinical trials
    Patel, S.
    Schernthaner, G.
    Barnett, A. H.
    Hehnke, U.
    von Eynatten, M.
    Woerle, H. -J.
    DIABETOLOGIA, 2013, 56 : S370 - S370
  • [24] Improvements in skin clearance and patient-reported signs and symptoms of psoriasis with brodalumab: Pooled analysis of phase 3 clinical studies
    Blauvelt, Andrew
    Gordon, Kenneth
    Leonardi, Craig
    Israel, Robert J.
    Jacobson, Abby
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB78 - AB78
  • [25] The Effect of Race on Treatment Response to Terlipressin in Patients with Hepatorenal Syndrome: A Pooled Analysis of 3 Phase III Clinical Studies
    Thuluvath, Paul J.
    Pyrsopoulos, Nikolaos T.
    Bhamidimarri, Kalyan Ram.
    Lim, Nicholas
    Jamil, Khurram
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S1083 - S1083
  • [26] One-Year Efficacy and Safety of Evolocumab in Japanese Patients - A Pooled Analysis From the Open-Label Extension OSLER Studies -
    Hirayama, Atsushi
    Yamashita, Shizuya
    Inomata, Hyoe
    Kassahun, Helina
    Cyrille, Marcoli
    Ruzza, Andrea
    Yoshida, Masayuki
    Kiyosue, Arihiro
    Ma, Yuhui
    Teramoto, Tamio
    CIRCULATION JOURNAL, 2017, 81 (07) : 1029 - +
  • [27] Safety of Bimekizumab in Patients with moderate to severe Psoriasis: Analysis of Pooled Data from Phase II and III Clinical Studies
    Reich, K.
    Blauvelt, A.
    Lebwohl, M.
    Papp, K. A.
    Rich, P.
    Strober, B.
    De Cuyper, D.
    Madden, C.
    Peterson, L.
    Vanvoorden, V.
    Warren, R. B.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 64 - 64
  • [28] Efficacy and safety of bempedoic acid in patients with heterozygous familial hypercholesterolemia: analysis of pooled patient-level data from phase 3 clinical trials
    Duell, Barton
    Banach, Maciej
    Catapano, Alberico L.
    Laufs, Ulrich
    Ray, Kausik K.
    Mancini, G. B. John
    Broestl, Christine
    Zhang, Yang
    Lei, Lei
    Goldberg, Anne C.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2024, 18 (02) : e153 - e165
  • [29] EFFICACY AND SAFETY OF BEMPEDOIC ACID IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: ANALYSIS OF POOLED PATIENT-LEVEL DATA FROM PHASE 3 CLINICAL TRIALS
    Duell, P. B.
    Banach, M.
    Catapano, A. L.
    Laufs, U.
    Mancini, G. B. J.
    Ray, K. K.
    Bloedon, L. T.
    Ye, Z.
    Goldberg, A. C.
    ATHEROSCLEROSIS, 2020, 315 : E12 - E13
  • [30] POOLED SAFETY ANALYSES FROM PHASE 3 STUDIES OF FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Bartok, Beatrix
    Winthrop, Kevin L.
    Genovese, Mark
    Combe, Bernard G.
    Tanaka, Yoshiya
    Kivitz, Alan
    Matzkies, Franziska
    Ye, Lei
    Guo, Ying
    Tasset, Chantal T.
    Sundy, John S.
    Keystone, Edward
    Westhovens, Rene
    Rigby, William
    Burmester, Gerd R.
    Walker, David R.
    GASTROENTEROLOGY, 2020, 158 (06) : S679 - S679